Nlgn4X Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Neuroligin 4 X-linked (NLGN4X) is a postsynaptic cell adhesion molecule encoded by the NLGN4X gene on chromosome Xp22.33. It plays critical roles in inhibitory synapse formation, function, and plasticity by mediating trans-synaptic interactions with presynaptic neurexins. NLGN4X is essential for normal social behavior, cognitive function, and synaptic plasticity. Mutations in NLGN4X are associated with autism spectrum disorder (ASD), intellectual disability, and have been implicated in Tourette syndrome and ADHD.
Key points:
- Postsynaptic cell adhesion molecule (X-linked)
- Predominantly involved in inhibitory (GABAergic) synapse formation
- Binds presynaptic neurexins to mediate synapse formation
- Essential for excitatory/inhibitory (E/I) balance
- Mutations cause autism spectrum disorder and X-linked intellectual disability
The NLGN4X gene encodes neuroligin-4X, a postsynaptic cell adhesion molecule predominantly involved in inhibitory synaptic transmission. Located on the X chromosome, NLGN4X is one of the most significant monogenic causes of autism spectrum disorder (ASD) and X-linked intellectual disability.
| Property |
Value |
| Gene Symbol |
NLGN4X |
| Full Name |
Neuroligin 4, X-linked |
| Chromosomal Location |
Xp22.33 |
| NCBI Gene ID |
54502 |
| OMIM ID |
300496 |
| Ensembl ID |
ENSG00000146938 |
| UniProt ID |
Q9H0Y5 |
NLGN4X spans approximately 30 kb on the X chromosome (Xp22.33) and consists of 20 exons encoding a protein of 1,595 amino acids. The gene structure follows the typical neuroligin architecture:
- Exons 1-16: Encode the extracellular domain (AChE-like domain)
- Exon 17: Encodes the transmembrane domain
- Exons 18-20: Encode the cytoplasmic tail with PDZ-binding motif
Multiple transcript variants have been identified, including:
- Full-length protein-coding transcript
- Alternatively spliced variants affecting the cytoplasmic domain
NLGN4X has distinct functional properties compared to other neuroligin family members:
-
Inhibitory Synapse Specialization: NLGN4X shows strong preference for inhibitory (GABAergic) synapses, unlike NLGN1 which favors excitatory synapses.
-
Synapse Induction: Mediates trans-synaptic adhesion with presynaptic neurexins, particularly NRXN1α.
-
Postsynaptic Scaffold Recruitment: Recruits gephyrin and other inhibitory postsynaptic scaffold proteins to organize GABA receptor clusters.
-
Synaptic Balance: Critical for maintaining excitatory/inhibitory (E/I) balance in neural circuits.
NLGN4X has a brain-specific expression pattern:
- Highest expression: Cerebral cortex, hippocampus, basal ganglia
- Moderate expression: Cerebellum
- Cellular localization: Neuronal postsynaptic membranes
NLGN4X is among the most common monogenic causes of ASD:
- Prevalence: Accounts for ~1-2% of monogenic ASD cases
- Mutation Types: Nonsense, frameshift, splice-site, and missense mutations
- First Identified Mutations: The R451H and Q429X mutations were described in initial studies
- Phenotype: ASD with moderate to severe intellectual disability
- X-linked ID: NLGN4X mutations cause approximately 1% of X-linked intellectual disability
- Non-syndromic ID: Some mutations cause ID without prominent ASD features
- Carrier females: May show milder phenotypic features due to X-chromosome inactivation
- Some studies have identified NLGN4X variants in individuals with attention-deficit/hyperactivity disorder.
- Rare associations have been reported in some families with tic disorders.
- Loss-of-Function: Truncating mutations lead to absent or non-functional protein
- Dominant-Negative: Some missense mutations may disrupt function of wild-type protein
- Synaptic Dysfunction: Impaired neurexin binding disrupts synaptic adhesion
- Inhibitory Circuitry: Specific disruption of GABAergic synaptic function
- Presynaptic: Neurexin-1α (NRXN1)
- Postsynaptic: Gephyrin, PSD-95, NLGN4X (homophilic)
- Gene Therapy: AAV-mediated NLGN4X delivery for loss-of-function mutations
- Protein Replacement: Direct delivery of functional neuroligin protein
- Small Molecule Modulators: Enhancement of remaining neuroligin function
- Symptomatic Treatment: Behavioral interventions, pharmacotherapy for comorbid conditions
- Nlgn4 Knockout Mice: Show reduced inhibitory synaptic transmission, impaired social interaction, and repetitive behaviors.
- Humanized Mouse Models: Expressing human NLGN4X with disease-causing mutations.
- Mutations in the NLGN4X gene cause autism and mental retardation — Cell, 2008
- Neuroligin-4 is required for inhibitory synapse function — Nature Neuroscience, 2011
- NLGN4X mutations and neurodevelopmental disorders — Molecular Psychiatry, 2016
The study of Nlgn4X Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.